Originally Posted by
dukkha
Pfizer is preparing for approval from the federal government and distribution of a vaccine before the end of the year.
"We started already manufacturing and we have already manufactured hundreds of thousands of doses, so just in case we have a good study readout, conclusive and FDA, plus the advisory committee feels comfortable that we will be ready," he said.
Pfizer, which has partnered with BioNtech on its coronavirus vaccine, has begun enrolling 30,000 people in its phase three vaccine trial but is looking to expand its enrollment to 44,000. Bourla said the decision to increase the number of participants stems from its desire to expand to more vulnerable populations.
"We go to younger people. Right now, the study recruits from 18 to 85. Now we will go to 16 years old," he said. "Also, we will go to people with special conditions, chronic conditions like HIV patients, but also we will try to use it to increase the diversity of the population."
While Pfizer is one of several companies currently enrolling participants in its phase three vaccine trial, it is the only U.S.-based pharmaceutical company that has rejected federal dollars for its vaccine candidate.
Knowing it works is half the battle. That means all they have left is to see if it has any adverse side effects over time. Then is the vaccine worth the risk of side effects. Once all that is done they can release to the public.
Are you going to take the vaccine if they have not tested for adverse side effects?
4,487
18 U.S. Code § 2071 - Concealment, removal, or mutilation generally
44 U.S.C. 2202 - The United States shall reserve and retain complete ownership, possession, and control of Presidential records; and such records shall be administered in accordance with the provisions of this chapter.
LOCK HIM UP!
Bookmarks